Sapropterin Dihydrochloride tablet bulk supplier for pharma manufacturers

Sapropterin Dihydrochloride Tablet 100 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100 mg

Reference Brands: Kuvan®(US); Kuvanon®(EU)

Sapropterin dihydrochloride enhances BH4 levels, a cofactor for phenylalanine hydroxylase, improving phenylalanine metabolism. It lowers blood phenylalanine levels, prevents neurological damage, and supports normal growth in phenylketonuria (PKU) patients. Benefits include improved metabolic control, dietary flexibility, and enhanced quality of life.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Sapropterin Dihydrochloride tablets, marketed as Kuvan®, are approved for treating phenylketonuria (PKU) in the US and EU. In the US, FDA approval includes a comprehensive dossier supporting safety, efficacy, and manufacturing standards. Similarly, the European Medicines Agency (EMA) has reviewed and approved Kuvan® based on rigorous assessments. These approvals ensure high-quality, stability, and consistent dosing. For pharmaceutical companies and stakeholders, detailed regulatory dossiers are available that outline clinical data, manufacturing practices, and compliance with international standards. For more insights on regulatory processes and dossiers, visit PharmaTradz.

Sapropterin Dihydrochloride Tablet — third party manufacturing & bulk supply

Sapropterin Dihydrochloride Tablet 100 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sapropterin Dihydrochloride Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sapropterin Dihydrochloride Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sapropterin Dihydrochloride Tablet →

Back to Listing

Frequently Asked Questions

Sapropterin Dihydrochloride tablet is listed as Tablets in 100 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Sapropterin Dihydrochloride tablet is referenced against Kuvan®(US); Kuvanon®(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.